August 29, 2016 12:56 AM ET


Company Overview of 23andMe, Inc.

Company Overview

23andMe, Inc. operates as a personal genetics company that provides DNA analysis services. The company offers information and tools for individuals to learn about and explore their DNA. It enables individuals to discover ancestral origins and trace the lineage with a personalized analysis of DNA. The company uses Illumina HumanOmniExpress-24 format chip that comprises a custom panel of probes for detecting genetic variations. Its Personal Genome Service enables individuals to gain deeper insights into their ancestry and inherited traits. The company also sells personalized genetics kits online. The company was founded in 2006 and is based in Mountain View, California.

899 West Evelyn Avenue

Mountain View, CA 94041

United States

Founded in 2006





Key Executives for 23andMe, Inc.

Co-Founder, Chief Executive Officer and Director
President and Director
Age: 49
Chief Financial Officer and Head of Operations
Age: 53
Chief Science Officer and Head of Therapeutics
Age: 63
Chief Medical Officer
Compensation as of Fiscal Year 2016.

23andMe, Inc. Key Developments

23andMe, Inc. Presents at UBS Genomics 2.0 Summit, Aug-10-2016 07:15 PM

23andMe, Inc. Presents at UBS Genomics 2.0 Summit, Aug-10-2016 07:15 PM. Venue: St. Regis Deer Valley, Park City, Utah, United States. Speakers: Andrew W. Page, President and Director.

23andMe Launches New Genotyping Services for Research Platform

23andMe announced the launch of its new Genotyping Services for Research (GSR) platform providing scientists with an end-to-end service to incorporate genetic information into their studies. 23andMe's GSR platform is for researchers recruiting participants for prospective studies and looking to generate genetic information from those cohorts. Researchers will be able to use 23andMe's GSR platform to track and manage their projects, and download data in real-time as samples are genotyped through the new 23andMe Researcher Dashboard. When paired with 23andMe's mobile API for ResearchKit, researchers will have the ability to create apps to collect digital phenotypes on smartphones to study alongside genetic information. The end-to-end service includes non-invasive sample collection, DNA extraction, genotyping (arrays, reagents and sample processing), data and project tracking for researchers, and return of 23andMe reports to participants. The GSR platform also simplifies the recruiting process, offering non-invasive sample collection through a simple saliva kit, and the ability to recruit nationally by shipping the 23andMe kit directly to participants' homes. Those who have signed on to pilot the GSR platform prior to full launch are conducting studies as varied as smoking cessation, cognitive impairment in glioma patients, as well as addictions and psychiatric disorders. The list of current collaborators includes researchers at the University of California, San Diego; the University of Southern California; and Washington University in St. Louis, among others.

23andMe, Inc Announces New ResearchKit Module

23andMe, Inc. announced a new ResearchKit module that allows researchers to seamlessly integrate genetic information into their app-based studies. ResearchKit, an open source software framework designed by Apple, makes it easy for researchers to create studies for iPhone. The Mount Sinai Asthma Health and Stanford Medicine's MyHeart Counts apps will be the first to implement the module, enabling more than 1.2 million 23andMe customers to upload their genetic information directly through the apps, following an informed consent process. The 23andMe module is available for ResearchKit developers this month. Another feature of the 23andMe module will allow interested researchers who are using the ResearchKit platform to expand the collection of genetic data for their studies beyond current 23andMe customers. Researchers could choose to offer genotyping services to their study participants through 23andMe, with the services being funded by the researchers. Participants will then have access to the full 23andMe service, and researchers will have a simple, low cost way to incorporate genetic data into their studies.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact 23andMe, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at